Medicare AWP Reform Would Cause Oncologists To Drop Patients, ASCO Says
Executive Summary
One in five oncologists will drop their Medicare patients if the AWP reform provisions of the House or Senate Medicare bills are enacted, the American Society of Clinical Oncology says
You may also be interested in...
Roche Will Challenge Amgen In U.S. EPO Market; Oncology Business Growing
Roche expects to enter the U.S. EPO market with the continuous erythropoetin receptor activator R-744, Global Pharmaceuticals Head William Burns told securities analysts during a July 23 meeting in Zurich
Roche Will Challenge Amgen In U.S. EPO Market; Oncology Business Growing
Roche expects to enter the U.S. EPO market with the continuous erythropoetin receptor activator R-744, Global Pharmaceuticals Head William Burns told securities analysts during a July 23 meeting in Zurich
AWP Settlements Unlikely To Resolve Pricing Issue, State Fraud Chief Says
Federal health care fraud prosecutions will not be sufficient to resolve the issues surrounding AWP price reporting, National Association of State Medicaid Fraud Control Units President Christopher Abruzzo told the 340B Coalition annual conference in Washington, D.C. July 16